Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 9267653, 7 pages
https://doi.org/10.1155/2018/9267653
Research Article

Effect of Qingxin Kaiqiao Fang on Hippocampus mRNA Expression of the Inflammation-Related Genes IL-1β, GFAP, and Aβ in an Alzheimer’s Disease Rat Model

1The Second Clinical College, Wenzhou Medical University, Wenzhou 325003, China
2The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, 109 Xue Yuan Xi Road, Lu Cheng District, Wenzhou 325000, China

Correspondence should be addressed to Hai-Yan Hu; moc.361@kyzxdkyzw

Received 24 August 2017; Accepted 18 January 2018; Published 18 February 2018

Academic Editor: Darren R. Williams

Copyright © 2018 Dan-Dan Mao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. E. Hebert, P. A. Scherr, J. L. Bienias, D. A. Bennett, and D. A. Evans, “Alzheimer disease in the US population: prevalence estimates using the 2000 census,” JAMA Neurology, vol. 60, no. 8, pp. 1119–1122, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. B. Maccioni, J. P. Muñoz, and L. Barbeito, “The molecular bases of Alzheimer's disease and other neurodegenerative disorders,” Archives of Medical Research, vol. 32, no. 5, pp. 367–381, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. R. Nicoll, M. Yamada, J. Frackowiak, B. Mazur-Kolecka, and R. O. Weller, “Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease: Pro-CAA position statement,” Neurobiology of Aging, vol. 25, no. 5, pp. 589–597, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Gorman, “Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling: Apoptosis Review Series,” Journal of Cellular and Molecular Medicine, vol. 12, no. 6, pp. 2263–2280, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. D. A. Butterfield, S. Griffin, G. Munch, and G. M. Pasinetti, “Amyloid β-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists,” Journal of Alzheimer's Disease, vol. 4, no. 3, pp. 193–201, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. E. Bamberger, M. E. Harris, D. R. McDonald, J. Husemann, and G. E. Landreth, “A cell surface receptor complex for fibrillar β-amyloid mediates microglial activation,” The Journal of Neuroscience, vol. 23, no. 7, pp. 2665–2674, 2003. View at Google Scholar · View at Scopus
  7. W. Hong and J. Y. Zhang, “Academic thoughts about dementia,” Hebei J TCM (China), vol. 22, pp. 551-552, 2000. View at Google Scholar
  8. Q. L. Yan and B. Xing, “Development of TCM treatment in Alzheimer's disease objective and method,” JTCM (China), vol. 44, pp. 725-726, 2003. View at Google Scholar
  9. Y. F. Wang and Q. L. Yan, “Uses the clearing method in the treatment of Alzheimers disease experience,” Jiangsu J Tradit Chin Med (China), vol. 25, pp. 10-11, 2004. View at Google Scholar
  10. Y. L. Zhang, D. M. Liou, W. u. QS, Y. Y. Yao, and W. P. Li, Effect of the extract of astragalus on learning and memory and the expression of Bcl-2 and Bcl-xl protein in hippocampus neurons in rat model with Alzheimer's Disease, vol. 242, Acta Universitatis Medicinalis Anhui, China, 2007.
  11. P. George and W. Charles, The rat brain in stereotaxic coordinates, Academic Press, California, USA, 3rd edition, 2007.
  12. H. Y. Hu, Q. Meng, Z. Jiang, W. M. Zhu, W. H. Wang, and X. Y. Zhang, “Effect of Qingxin Kaiqiao Fang on learning and memory ability and morphology of hippocampal nerve cells in AD mice,” China Journal of Chinese Material Medico (China), vol. 33, pp. 1183–1187, 2008. View at Google Scholar
  13. W. M. Zhu, Q. Meng, Z. Jiang, H. u. HY, W. H. Wang, and X. Y. Zhang, “Effect of Qingxin Kaiqiaofang treatment in AD mice on learning and memory ability as well as the contents of NO AchE in mouse brain,” Chinese Archives of Traditional Chinese Medicine (China), vol. 26, pp. 2269–2271, 2008. View at Google Scholar
  14. T. Hong, Infectious & Non-Infectious Dementia Prion & Alzheimers Disease, Science Press, Bering, 2001.
  15. W.-Q. Zhao, F. G. de Felice, S. Fernandez et al., “Amyloid beta oligomers induce impairment of neuronal insulin receptors,” The FASEB Journal, vol. 22, no. 1, pp. 246–260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. K. L. Viola, P. T. Velasco, and W. L. Klein, “Why Alzheimer’s disease is a disease of memory: the attack on synapses by A-beta oligomers (ADDLs),” The Journal of Nutrition, Health & Aging, vol. 12, no. S1, pp. S51–S57, 2008. View at Publisher · View at Google Scholar
  17. S. Vasto, G. Candore, F. Listì et al., “Inflammation, genes and zinc in Alzheimer's disease,” Brain Research Reviews, vol. 58, no. 1, pp. 96–105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Ojala, I. Alafuzoff, S.-K. Herukka, T. van Groen, H. Tanila, and T. Pirttilä, “Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients,” Neurobiology of Aging, vol. 30, no. 2, pp. 198–209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. T. Gulledge and G. J. Stuart, “Cholinergic inhibition of neocortical pyramidal neurons,” The Journal of Neuroscience, vol. 25, no. 44, pp. 10308–10320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Watanabe, N. Yamagata, K. Takasaki et al., “Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's disease,” Brain Research, vol. 1249, pp. 222–228, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Muntané, E. Dalfó, A. Martinez, and I. Ferrer, “Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related α-synucleinopathies,” Neuroscience, vol. 152, no. 4, pp. 913–923, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. D. P. Hanger, B. H. Anderton, and W. Noble, “Tau phosphorylation: the therapeutic challenge for neurodegenerative disease,” Trends in Molecular Medicine, vol. 15, no. 3, pp. 112–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. O. Thibault, J. C. Gant, and P. W. Landfield, “Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store,” Aging Cell, vol. 6, no. 3, pp. 307–317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. K.-H. Cheung, D. Shineman, M. Müller et al., “Mechanism of Ca2+ Disruption in Alzheimer's Disease by Presenilin Regulation of InsP3 Receptor Channel Gating,” Neuron, vol. 58, no. 6, pp. 871–883, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Reed, M. Perluigi, R. Sultana et al., “Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease,” Neurobiology of Disease, vol. 30, no. 1, pp. 107–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. R. D. Moir and R. E. Tanzi, “LRP-mediated clearance of Aβ is inhibited by KPI-containing isoforms of APP,” Current Alzheimer Research, vol. 2, no. 2, pp. 269–273, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. H. S. Zhang, Q. Lin, and D. H. Yang, “Research progress of a ß toxicity mechanism of Alzheimer's disease,” China Modern Medicine, vol. 16, pp. 23-24, 2009. View at Google Scholar
  28. T. D. Stein, N. J. Anders, C. DeCarli, S. L. Chan, M. P. Mattson, and J. A. Johnson, “Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSw mice resulting in tau phosphorylation and loss of hippocampal neurons: Support for the amyloid hypothesis,” The Journal of Neuroscience, vol. 24, no. 35, pp. 7707–7717, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. W. J. Streit, “Microglia and Alzheimer's disease pathogenesis,” Journal of Neuroscience Research, vol. 77, no. 1, pp. 1–8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Klyubin, D. M. Walsh, C. A. Lemere et al., “Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo,” Nature Medicine, vol. 11, no. 5, pp. 556–561, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. G. S. Ma, S. D. Chen, M. W. Ba et al., “Aβ Induced Glioma cell U251 protein aggregates formation of oxygen content and mitochondrial membrane potential increase,” Chin J Neural, vol. 38, pp. 265-266, 2005. View at Google Scholar
  32. M. J. Rowan, I. Klyubin, Q. Wang, and R. Anwyl, “Synaptic plasticity disruption by amyloid β protein: Modulation by potential Alzheimer's disease modifying therapies,” Biochemical Society Transactions, vol. 33, no. 4, pp. 563–567, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. R. G. Nagele, M. R. D'Andrea, H. Lee, V. Venkataraman, and H.-Y. Wang, “Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains,” Brain Research, vol. 971, no. 2, pp. 197–209, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Blum-Degen, T. Müller, and W. Kuhn, “Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer’s and de novo Parkinson’s disease patients,” Neuroscience Letters, vol. 202, pp. 17–20, 1995. View at Publisher · View at Google Scholar
  35. D. Goldgaber, H. W. Harris, T. Hla et al., “Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 86, no. 19, pp. 7606–7610, 1989. View at Publisher · View at Google Scholar · View at Scopus
  36. M. M. Halassa and P. G. Haydon, “Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior,” Annual Review of Physiology, vol. 72, pp. 335–355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. C. S. Chiang, A. Stalder, A. Samimi, and I. L. Campbell, “Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice,” Developmental Neuroscience, vol. 16, no. 3-4, pp. 212–221, 1994. View at Publisher · View at Google Scholar · View at Scopus